Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
N4 Pharma ( (GB:N4P) ) has shared an announcement.
N4 Pharma has announced an Investor Insight Event for retail investors on July 14, 2025, at the Royal College of Surgeons in London. The event will feature strategic updates on the development of Nuvec® for RNA therapeutics, presentations from senior leadership, and opportunities for direct engagement with the executive team, reflecting the company’s commitment to transparency and stakeholder engagement.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system aimed at advancing therapies for cancer and other diseases.
Average Trading Volume: 1,718,567
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.